Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Fanny Monneaux

Showing results (11-20 of 26) with videos related to

Pageof 3
Sort By:
European Journal of Immunology|January 28, 2003
T cell recognition and therapeutic effect of a phosphorylated synthetic peptide of the 70K snRNP protein administered in MR/lpr miceFanny Monneaux, José Manuel Lozano, Manuel E Patarroyo, et al.
Immunotargets and Therapy|January 23, 2025
Targeting B and T Lymphocyte Attenuator Regulates Lupus Disease Development in NZB/W MiceLéa Gherardi, Lucie Aubergeon, Mélanie Sayah, et al.
Frontiers in Immunology|December 13, 2021
High BTLA Expression Likely Contributes to Contraction of the Regulatory T Cell Subset in Lupus DiseaseLucie Aubergeon, Matthieu Sawaf, Renaud Felten, et al.
Organic & Biomolecular Chemistry|March 12, 2011
The stimulating adventure of KRN 7000Aline Banchet-Cadeddu, Eric Hénon, Manuel Dauchez, et al.
Plos One|January 17, 2012
Disease progression in MRL/lpr lupus-prone mice is reduced by NCS 613, a specific cyclic nucleotide phosphodiesterase type 4 (PDE4) inhibitorThérèse Keravis, Fanny Monneaux, Issaka Yougbaré, et al.
Plos One|September 27, 2013
Circulating TFH subset distribution is strongly affected in lupus patients with an active diseaseCarole Le Coz, Aurélie Joublin, Jean-Louis Pasquali, et al.
JCI Insight|July 13, 2018
Defective BTLA functionality is rescued by restoring lipid metabolism in lupus CD4+ T cellsMatthieu Sawaf, Jean-Daniel Fauny, Renaud Felten, et al.
Journal of Virology|September 15, 2007
Influenza virus-induced type I interferon leads to polyclonal B-cell activation but does not break down B-cell toleranceAnne Woods, Fanny Monneaux, Pauline Soulas-Sprauel, et al.
Journal of Immunology (Baltimore, Md. : 1950)|October 21, 2005
Selective modulation of CD4+ T cells from lupus patients by a promiscuous, protective peptide analogFanny Monneaux, Johan Hoebeke, Christelle Sordet, et al.
Arthritis and Rheumatism|November 28, 2008
Spliceosomal peptide P140 for immunotherapy of systemic lupus erythematosus: results of an early phase II clinical trialSylviane Muller, Fanny Monneaux, Nicolas Schall, et al.
Pageof 3

Showing results (11-20 of 26) with videos related to

Sort By:
Pageof 3
European Journal of Immunology|January 28, 2003
T cell recognition and therapeutic effect of a phosphorylated synthetic peptide of the 70K snRNP protein administered in MR/lpr miceFanny Monneaux, José Manuel Lozano, Manuel E Patarroyo, et al.
Immunotargets and Therapy|January 23, 2025
Targeting B and T Lymphocyte Attenuator Regulates Lupus Disease Development in NZB/W MiceLéa Gherardi, Lucie Aubergeon, Mélanie Sayah, et al.
Frontiers in Immunology|December 13, 2021
High BTLA Expression Likely Contributes to Contraction of the Regulatory T Cell Subset in Lupus DiseaseLucie Aubergeon, Matthieu Sawaf, Renaud Felten, et al.
Organic & Biomolecular Chemistry|March 12, 2011
The stimulating adventure of KRN 7000Aline Banchet-Cadeddu, Eric Hénon, Manuel Dauchez, et al.
Plos One|January 17, 2012
Disease progression in MRL/lpr lupus-prone mice is reduced by NCS 613, a specific cyclic nucleotide phosphodiesterase type 4 (PDE4) inhibitorThérèse Keravis, Fanny Monneaux, Issaka Yougbaré, et al.
Plos One|September 27, 2013
Circulating TFH subset distribution is strongly affected in lupus patients with an active diseaseCarole Le Coz, Aurélie Joublin, Jean-Louis Pasquali, et al.
JCI Insight|July 13, 2018
Defective BTLA functionality is rescued by restoring lipid metabolism in lupus CD4+ T cellsMatthieu Sawaf, Jean-Daniel Fauny, Renaud Felten, et al.
Journal of Virology|September 15, 2007
Influenza virus-induced type I interferon leads to polyclonal B-cell activation but does not break down B-cell toleranceAnne Woods, Fanny Monneaux, Pauline Soulas-Sprauel, et al.
Journal of Immunology (Baltimore, Md. : 1950)|October 21, 2005
Selective modulation of CD4+ T cells from lupus patients by a promiscuous, protective peptide analogFanny Monneaux, Johan Hoebeke, Christelle Sordet, et al.
Arthritis and Rheumatism|November 28, 2008
Spliceosomal peptide P140 for immunotherapy of systemic lupus erythematosus: results of an early phase II clinical trialSylviane Muller, Fanny Monneaux, Nicolas Schall, et al.
Pageof 3